Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$453M |
| 2 |
CELG
Celgene Corp
CELG
|
+$391M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$389M |
| 4 |
GE Aerospace
GE
|
+$378M |
| 5 |
Johnson & Johnson
JNJ
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$307M |
| 2 |
Costco
COST
|
+$279M |
| 3 |
Lowe's Companies
LOW
|
+$273M |
| 4 |
Microsoft
MSFT
|
+$230M |
| 5 |
Chevron
CVX
|
+$225M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.07% |
| 2 | Technology | 14.35% |
| 3 | Financials | 11.23% |
| 4 | Consumer Discretionary | 9.93% |
| 5 | Real Estate | 8.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2351
Bridgewater Bancshares
BWB
$625M
| $1.9M | ﹤0.01% |
164,679
+72,869
| +79% | +$793K |
|
2352
Atkore
ATKR
$3.17B
| $1.89M | ﹤0.01% |
73,200
-78,800
| -52% | -$1.92M |
|
2353
Full House Resorts
FLL
$85.4M
| $1.89M | ﹤0.01% |
1,010,023
+31,931
| +3% | +$67.9K |
|
|
AFI
2354
DELISTED
Armstrong Flooring, Inc.
AFI
| $1.88M | ﹤0.01% |
191,100
-197,500
| -51% | -$2.44M |
|
|
QTRH
2355
DELISTED
Quarterhill Inc. Common Shares
QTRH
| $1.88M | ﹤0.01% |
1,740,007
+61,476
| +4% | +$66.7K |
|
2356
Liberty Latin America Class A
LILA
$1.67B
| $1.87M | ﹤0.01% |
169,298
-46,790
| -22% | -$573K |
|
2357
Global Ship Lease
GSL
$1.51B
| $1.87M | ﹤0.01% |
252,975
+26,750
| +12% | +$169K |
|
2358
Genco Shipping & Trading
GNK
$1.14B
| $1.86M | ﹤0.01% |
221,000
-113,930
| -34% | -$943K |
|
2359
State Street SPDR S&P Regional Banking ETF
KRE
$4.69B
| $1.86M | ﹤0.01% |
+34,900
| New | +$1.86M |
|
2360
Metropolitan Bank Holding Corp
MCB
$1.17B
| $1.86M | ﹤0.01% |
42,300
+18,000
| +74% | +$716K |
|
|
HNP
2361
DELISTED
Huaneng Power Intl, Inc.
HNP
| $1.86M | ﹤0.01% |
79,700
+40,600
| +104% | +$983K |
|
2362
Comstock Resources
CRK
$4.1B
| $1.86M | ﹤0.01% |
333,400
-234,600
| -41% | -$1.36M |
|
|
TST
2363
DELISTED
TheStreet, Inc.
TST
| $1.85M | ﹤0.01% |
302,404
+21,948
| +8% | +$233K |
|
2364
Mammoth Energy Services
TUSK
$158M
| $1.85M | ﹤0.01% |
269,400
+187,300
| +228% | +$2.38M |
|
|
IMI
2365
DELISTED
Intermolecular, Inc.
IMI
| $1.85M | ﹤0.01% |
1,583,367
+96,689
| +7% | +$111K |
|
2366
Lantronix
LTRX
$287M
| $1.85M | ﹤0.01% |
555,764
-147,000
| -21% | -$506K |
|
|
PSDO
2367
DELISTED
Presidio, Inc. Common Stock
PSDO
| $1.85M | ﹤0.01% |
135,200
-158,400
| -54% | -$2.23M |
|
|
BBU
2368
DELISTED
Brookfield Business Partners
BBU
| $1.84M | ﹤0.01% |
74,395
-13,715
| -16% | -$339K |
|
|
TCO
2369
DELISTED
Taubman Centers Inc.
TCO
| $1.84M | ﹤0.01% |
45,100
-185,700
| -80% | -$8.94M |
|
2370
Vornado Realty Trust
VNO
$7.28B
| $1.84M | ﹤0.01% |
28,699
-267,300
| -90% | -$18M |
|
|
MBCN
2371
DELISTED
Middlefield Banc Corp
MBCN
| $1.84M | ﹤0.01% |
89,654
+42,544
| +90% | +$853K |
|
2372
American Coastal Insurance
ACIC
$463M
| $1.84M | ﹤0.01% |
128,753
+81,853
| +175% | +$1.22M |
|
|
COOP
2373
DELISTED
Mr. Cooper
COOP
| $1.83M | ﹤0.01% |
227,999
-236,700
| -51% | -$1.99M |
|
2374
Chicago Rivet & Machine Co
CVR
$9.98M
| $1.83M | ﹤0.01% |
64,110
+926
| +1% | +$26.3K |
|
|
XENT
2375
DELISTED
Intersect ENT, Inc
XENT
| $1.82M | ﹤0.01% |
80,200
+36,300
| +83% | +$979K |
|
Similar funds
Jim Simons's Q2 2019 Portfolio in Review
As of Q2 2019, Jim Simons held 3,913 positions worth $114B, up 3.3% from $110B the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.
Jim Simons's Q2 2019 filing shows 495 new, 1,847 increased, 1,145 reduced and 397 closed positions. Its largest new stake was Apple: 9,290,160 shares worth $460M. The largest sale was UnitedHealth, an estimated $307M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 17% a quarter earlier, followed by Technology and Financials.
- Jim Simons's largest Q2 2019 buy was Apple: 9,290,160 shares worth $460M.
- Jim Simons added most to Celgene Corp in Q2 2019, an estimated $391M increase.
- Jim Simons's biggest Q2 2019 reduction was Microsoft, cutting an estimated $230M.
- Jim Simons fully exited UnitedHealth in Q2 2019, selling an estimated $307M.
- Jim Simons's ten largest holdings make up 9.1% of its $114B portfolio in Q2 2019.
- Jim Simons opened 495 new positions and closed 397 in Q2 2019.
- Jim Simons's portfolio value rose 3.3% quarter-over-quarter to $114B.
Based on Renaissance Technologies's 13F filing for Q2 2019, filed 12 Aug 2019.